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Background: Preconception care (PCC) is recommended for optimizing a woman’s health prior to pregnancy to
minimize the risk of adverse pregnancy and birth outcomes. We aimed to evaluate the impact of strategy and a
novel risk classification model of China´s “National Preconception Health Care Project” (NPHCP) in identifying risk
factors and stratifying couples’ preconception health status.
Methods: We performed a secondary analysis of data collected by NPHCP during April 2010 to December 2012 in
220 selected counties in China. All couples enrolled in the project accepted free preconception health examination,
risk evaluation, health education and medical advice. Risk factors were categorized into five preconception risk
classes based on their amenability to prevention and treatment: A-avoidable risk factors, B- benefiting from
targeted medical intervention, C-controllable but requiring close monitoring and treatment during pregnancy,
D-diagnosable prenatally but not modifiable preconceptionally, X-pregnancy not advisable. Information on each
couple´s socio-demographic and health status was recorded and further analyzed.
Results: Among the 2,142,849 couples who were enrolled to this study, the majority (92.36%) were from rural areas
with low education levels (89.2% women and 88.3% men had education below university level). A total of 1463266
(68.29%) couples had one or more preconception risk factors mainly of category A, B and C, among which 46.25%
were women and 51.92% were men. Category A risk factors were more common among men compared with
women (38.13% versus 11.24%; P = 0.000).
Conclusions: This project provided new insights into preconception health of Chinese couples of reproductive
age. More than half of the male partners planning to father a child, were exposed to risk factors during the
preconception period, suggesting that an integrated approach to PCC including both women and men is justified.
Stratification based on the new risk classification model demonstrated that a majority of the risk factors are
avoidable, or preventable by medical intervention. Therefore, universal free PCC can be expected to improve
pregnancy outcomes in rural China.
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Preconception care (PCC) is defined as interventions
that aim to identify and, when possible, modify the bio-
medical, behavioral, and social risks to optimize woman’s
health before pregnancy with the aim of improving preg-
nancy outcomes [1]; In 2014, Centers for Disease
Control and Prevention (CDC) and the Office of Popula-
tion Affairs published clinical recommendations, “Providing
Quality Family Planning Services” (QFP), and recognized
PCC as a critical component of health care for women of
reproductive age [2].
The purpose of PCC is to optimize a woman’s health
prior to pregnancy and promote healthy behavior during
pregnancy to reduce the incidence of adverse birth out-
comes [3]. It is reported that an estimated 300,000
women die globally as a result of pregnancy-related con-
ditions [4]. The prevalence of birth defects in China is
around 5.6%, and there are nearly 900 000 new cases an-
nually according to the official Report on Prevention of
Birth Defects in China published in 2012 [5]. Health ser-
vices provided to the couples of reproductive age, such
as family planning, folic acid supplementation [6], gen-
etic counseling, chronic disease management, immuni-
zations, treatment of sexually transmitted infections,
and interventions promoting healthier lifestyle, including
those directed against alcohol, tobacco, and substance
abuse [7] seem to have a positive effect. There is growing
evidence that effective treatment of maternal diabetes and
hypertension during the preconception period reduces
adverse maternal and neonatal outcomes [8–10]. Avoiding
unintended pregnancy through PCC could avert 44%
maternal mortality [11]. Moreover, the effect of PCC
on women with a history of previous adverse infant
outcome, such as preterm birth, low birth weight,
stillbirth or major birth defect, appears to be mean-
ingful [12].
Even though the benefits of PCC have been well estab-
lished [13, 14], integrating PCC into regular family
planning services still remains a challenge for some pro-
viders [15]. Poor organization of health services’ delivery
systems, lack of comprehensive PCC programs, limited
awareness among future parents about the availability
and benefits of PCC and that of physicians about the
necessity and effectiveness of PCC are apparent barriers
affecting delivery and uptake of PCC [16, 17].
PCC in China has been insufficient and inadequate, es-
pecially in rural areas, despite the fact that facility-based
strategy on reducing neonatal mortality had a significant
impact on the Millennium Development Goal 4, and
with a rapid economic development there have been im-
provements in population health in recent decades [18].
Therefore, the National Health and Family Planning
Commission of the People’s Republic of China(NHFP-
C)launched the “National Preconception Health CareProject” (NPHCP) in 2010, focusing on rural areas and
providing free PCC for the couples of reproductive age
[19]. In this project, relevant preconception risk factors
were classified according to their amenability to preven-
tion and treatment. The objective of our study was to
evaluate the impact of strategy and risk classification
model of China’s NPHCP in identifying risk factors and
stratifying the preconception health status of men and
women of reproductive age.
Methods
Data source and study design
We conducted a secondary analysis of data collected
within the framework of NPHCP during April 2010
to December 2012 to investigate the characteristics
of preconception risk factors among married Chinese
women and men of reproductive age. Methodological
details of the project have been described previously
[20–22]. Briefly, the study covered 220 counties in China.
Selected rural counties in all provinces and the urban
counties that wanted to participate in this project were in-
cluded in this population-based prospective cohort study.
NHFPC established the implementation and quality
control standards for this program [20, 21]. Local com-
munity staff investigated the conception plans of the
couples, and those planning to conceive within the
next six months were enrolled and invited to attend a
free health examination. Professional doctors specially
trained in obstetrics, genetic and other related special-
ties provided necessary medical advice to the couples.
NHFPC has drafted and published the consultation
guide for common preconception health problems. All
couples enrolled accepted a free preconception health
examination, risk evaluation, health education and med-
ical advice based on the risk factors. A written informed
consent was obtained from each participant, and this
study was approved by the Institutional Review Board of
the Chinese Association of Maternal and Child Health
Studies [20, 21].
Preconception examination included (1) a medical
history: current medical illness and use of any medica-
tion, family history of hypertension, diabetes, congeni-
tal or genetic diseases in the first-degree relatives, life
style, dietary habits and exposure to environmental
and occupational hazards; (2) physical examination:
height, weight, blood pressure, heart rate, palpation of
thyroid gland, auscultation of the heart and lungs, ab-
dominal palpation, examination of the limbs and the
spine; (3) clinical laboratory tests: genital swabs for
microbiological culture and sensitivity, gonococcus
and chlamydia test, hemoglobin and full blood count,
urine for bacteriology and culture, blood type, serum
glucose, liver, renal function and thyroid function tests,
hepatitis B serology, syphilis test, TORCH (toxopasma,
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screen, and gynecological ultrasound; (4) past medical
history: hypertension, diabetes, cardiac diseases, im-
mune system diseases, renal diseases and other chronic
diseases; (5) past obstetric history including history of
induced abortion, spontaneous abortion, live birth,
stillbirth, neonatal death, fetal abnormality, preterm
birth and multiple pregnancy. Trained staff regularly
recorded and entered the information into the NHFPC
database.
Preconception risk evaluation and classification model
The aim of the preconception health examination was
to identify all the risk factors as far as possible, and
treat accordingly. Therefore, instead of assessing the
degree of exposure, we developed a preconception risk
classification system based on their amenability to
prevention and treatment according to Preconception
Health Examination and Risk Evaluation Guides (Science
and Technology Division of NHFPC) (Table 1). RiskTable 1 Definition of “ABCDX” category of preconception risk factor
Category Definition
A Avoidable risks, i.e. they could be avoided though health
education and eliminating work place hazards etc.
B Benefiting from targeted medical intervention,
C Controllable risk factors, i.e. diseases and conditions that
can’t be cured but risk can be modified and ameliorated.
Close monitoring and medical supervision is required
during the pregnancy
D Diagnosable prenatally but risk factor is not modifiable
preconceptionally i.e. women with these risk factors
may benefit from preconception risk evaluation, counseling
and prenatal diagnosis.
X Women with these risk factors are advised against pregnancy.
Pregnancy should be evaluated under specialist after treatment.
aAnemia referred to haemoglobin ranging from 60–109g/L
bThrombocytopenia referred to platelet ranging from 50 to 100*109/L
cSevere thrombocytopenia referred to platelet less than 50*109/L
dSevere anemia referred to haemoglobin less than 60g/Lfactors were categorized into five preconception risk
classes: A-avoidable risk factors, B-benefiting from tar-
geted medical intervention before conception, C-con-
trollable but requiring close monitoring and treatment
during pregnancy, D-diagnosable prenatally but the
risk factor not modifiable preconceptionally, X-preg-
nancy not advisable. The couples with category X risk
factor were advised to use appropriate contraception and
were considered in further analysis. Participants with miss-
ing or incomplete records were excluded from analysis.
Statistical analysis
Statistical analysis was performed using SPSS statistical
software version 15.0 (SPSS, System for Windows, Chi-
cago, USA). Data are presented as number (%) and
mean ± standard deviation (SD). For comparing groups,
we used independent samples t-test for continuous vari-
able and χ2 test for categorical variables. All P-values
were two-tailed, and a P < 0.05 was considered to be sta-
tistically significant.s
Risk factors
Maternal: smoking, alcohol consumption, exposure to toxins,
radiation, noise, pesticide, organic solvent, heavy metal, inadequate
nutrition (no intake of meat and egg, no intake of fresh vegetables,
raw meat eating habit)
Paternal: smoking, alcohol, consumption, exposure to toxins,
radiation exposure, noise, pesticide, organic solvent, high temperature,
preputial ring, inadequate nutrition (no intake of meat and egg,
no intake of fresh vegetables, raw meat eating habit)
Maternal: anemiaa, bacterial vaginitis, candida infection, gonorrhoea,
trichomoniasis, Toxoplasma gondii infection (IgM positive), gingival
hemorrhage, history of psychological disorder;
Paternal: abnormal liver function, abnormal renal function, spermatic
cord varicocele, hypertension, congenital heart disease, history of
chronic renal disease history, cancer, epilepsy, or psychological disorder
Maternal: Thrombocytopeniab, abnormal liver function, abnormal
renal function, abnormal TSH, HBs-Ag positive, HBe-Ag positive,
cytomegalovirus IgM positive, chlamydia positive, syphilis screening
positive, Rh negative, history of gynecological diseases, preterm birth,
diabetes, congenital heart disease, hypertension, malignancy,
chronic renal disease, reported epilepsy, tuberculosis, use of narcotics;
Paternal: HBs antigen positive, HBe antigen positive, syphilis screening
positive, use of narcotics, thyroid disease
Maternal: Maternal birth defect, history of previous child with birth
defects, mental retardation, history of recurrent abortion, stillbirth,
or neonatal death, family history of Mediterranean anemia, G6PD
deficiency, Albinism, Down’s syndrome, visual impairment;
hearing impairment;
Paternal: Paternal birth defect, mental retardation, family history
of neonatal death, Mediterranean anemia, G6PD deficiency,
Albinism, Down’s syndrome, hemophilia, family history of visual
impairment or hearing impairment
Maternal: severe heart failure, severe thrombocytopeniac, severe anemiad
Table 2 Socio-demographic characteristics of women in different preconception risk factor classification categories
No risk factors A B C D X
Age ≤25 24.7% 21.6% 26.3% 22.4% 14.7% 21.3%
25–30 46.3% 47.4% 46.7% 44.1% 38.5% 46.0%
30–35 19.5% 21.2% 18.2% 20.9% 27.1%* 20.1%
≥35 9.6% 9.8% 8.7% 12.6% 19.8%* 12.6%*
Area Rural area 93.9% 89.6% 94.0% 94.0% 94.3% 92.2%
Race Han 92.7% 91.6% 92.5% 88.7% 84.0%* 84.2%*
Education Secondary school or lower 71.5% 64.8%* 69.4% 71.8% 77.4% 75.5%
High school 18.7% 19.7% 18.7% 17.1% 13.8%* 16.6%
College or higher 9.8% 15.5%* 11.8% 11.1% 8.8% 8.0%
*P value <0.05 compared with those women having no risk factors
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General characteristics of the study population
During April 2010 to December 2012, a total of 22.42
million married Chinese couples planning to conceive
within the six months were recruited to the study from
220 different counties. After excluding those with in-
complete medical records and lost to follow-up, data
from 2,142,849 couples were available for analysis.
NPHCP targeted couples of reproductive age mainly
from rural areas, and covered most areas, regions, and
ethnicities from all provinces of mainland China. 92.36%
couples were from rural areas and 89.2% women and
88.3% men had education below university level. Other
socio-demographic details of the participants are pre-
sented in Tables 2 and 3.Preconception risk factor classification
As demonstrated in Tables 2 and 3, category D risk was
more common among couples in the age group 30–35
years and >35 years (P < 0.05). There were no significant
differences between rural areas and cities in both cou-
ples in terms of risk factor categories. Proportionally,






Area Rural area 92.6%
Race Han 92.7%
Education Secondary school or lower 69.3%
High school 20.0%
College or higher 10.6%
*:P value <0.05 compared with those men having no risk factorscategory D and X compared to those with no risk fac-
tors, while there was no difference in that ratio among
men. Women with category A, and men with category B
and D risk factors had higher education levels (P < 0.05).Distribution preconception risk factors
Distribution of the participants in different preconcep-
tion risk categories is presented in Table 4. Among
2,142,849 couples, 46.25% women had preconception
risks, mainly of category A, B and C. 9.80% women had
category A risks including alcohol consumption (3.4%),
inadequate protein intake (1.36%) and exposure to noise
(1.18%). 14.83% women were had category B risks, such
as anemia (8.40%), gingival hemorrhage (3.57%) and
vaginitis (2.29%). Moreover, 23.5% of women had cat-
egory C risks, such as thyroid dysfunction (6.34%), HBV
infection (4.76%), history of gynecological diseases
(3.41%) and/or category D risks, such as history of spon-
taneous abortion (2.66%) and adverse pregnancy history
(1.12%). On the other hand, 51.92% of couples had
paternal risks, and 38.13% of them had category A risk
factors including alcohol (29.61%) and smoking (29.07%)
(Table 4).nception risk categories
A B C D X
10.2% 10.3% 9.1% 4.5%* -
44.5% 44.9% 45.5% 38.6%* -
27.6% 28.0% 28.1% 33.0%* -
17.6% 16.8% 17.3% 23.9%* -
92.1% 90.1% 92.2% 85.7% -
91.3% 88.4% 92.3% 91.1% -
69.0% 63.1% 66.4% 61.9% -
19.2% 20.1% 20.2% 16.9% -
11.8% 16.8%* 13.4% 21.3%* -
Table 4 Distribution of preconception risk factors among women and men in different preconception risk categories
Risk factors Total number (%) Risk factors Total number (%)
Maternal Paternal
A
Alcohol consumption 72,808(3.40%) Alcohol consumption 634,547(29.61%)
No intake meat and egg 29,126(1.36%) Smoking 622,834(29.07%)
Noise exposure 25,267(1.18%) Preputial ring 84,659(3.95%)
Othersa 82,739(3.86%) Noise exposure 48,399(2.26%)
Pesticide exposure 26,753(1.25%)
No intake meat and egg 25,857(1.21%)
Organic solvent exposure 24,211(1.13%)
High temperature exposure 23,388(1.09%)
Othersi 41,492(1.94%)
B
Anemiab 179,941(8.40%) Abnormal liver function 152,862(7.13%)
Gingival hemorrhage 76,595(3.57%) Abnormal renal function 26,107(1.22%)
Vaginitisc 49,162(2.29%) Othersj 9,973(0.47%)
Othersd 12,257(0.57%)
C
Abnormal TSH 135,958(6.34%) HBs antigen positive 135,958(5.87%)
HBs-Ag positive 101,970(4.76%) HBe antigen positive 101,970(1.68%)
Gynecological diseases history 73,107(3.41%) Othersk 10,111(0.47%)
Abnormal renal function 57,680(2.69%)





Spontaneous abortion history 57,060(2.66%) Othersl 4,305(0.20%)




aincluding 20,647 not eating fresh vegetables (0.96%), 16,435 pesticide exposure (0.77%), 16,049 organic solvent exposure (0.75%), 12,540 radiation exposure
(0.59%), 9,717 smoking (0.45%), 5,582 raw meat eating habit (0.26%) and 1,765 heavy metal exposure (0.08%)
bAnemia referred to hemoglobin ranging from 60–109g/L
cVaginitis included 27,657 Candida infection, 11,398 Bacterial vaginitis and 10,107 Trichomonasis
dincluding 10,107 Trichomoniasis (0.47%), 7,672 Toxoplasma gondiiIgM positive (0.36%), 4,545Gonococcal infection (0.21%) and 40 history of psychological disease (0.00%)
eincluding 20,705 Rh negative (0.97%), 9,290 Cytomegalovirus IgM positive (0.43%), 9,266 Chlamydia positive (0.43%), 8,482 Syphilis screening positive (0.40%),
4,395 history of preterm birth (0.21%), 14,383 diabetes (0.67%), 1,830 reported hypertension (0.09%), 1,655 reported history of tuberculosis (0.08%), 1,392
anesthetic drug use (0.07%), 1,327 congenital heart disease (0.06%), 1,018 reported tumor history (0.05%), 897 reported chronic renal disease history (0.04%) and
882 reported epilepsy history (0.04%)
fAdverse pregnancy history included 16,824 with history of stillbirth and 7,054 with history of birth defects
gincluding 4,515 with birth defects (0.21%), 1,527 family history of neonatal death (0.07%), 1,416 mental retardation (0.07%), 923 family history of Mediterranean
anemia (0.04%), 254 family history of G6PD deficiency (0.01%), 138 family history of Albinism (0.01%), 92 family history of Down’s syndrome (0.00%), 5 family
history of hearing impairment (0.00%), 2 family history of mental retardation (0.00%) and 1family history of visual impairment (0.00%)
hincluding 2,707 severe thrombocytopenia (0.13%) and 2,552 severe anemia (0.12%). Severe thrombocytopenia referred to platelet less than 50*109/L. Severe
anemia referred to hemoglobin less than 60g/L
iincluding 18,726 not eating fresh vegetables (0.87%), 9,734 radiation exposure (0.45%), 9,454 raw meat eating habit (0.44%) and 3,578 exposure to heavy metals (0.17%)
jincluding 5,325 spermatic cord varicocele (0.25%), 2,432 hypertension (0.11%), 1,052 congenital heart disease (0.05%), 598 chronic renal disease history (0.03%),
404 epilepsy (0.02%), 159 history of cancer (0.01%) and 3 history of psychological disease (0.00%)
kincluding 7,771 Syphilis screening positive (0.36%), 1,348 anesthetic drug use (0.06%) and 992 reported thyroid disease (0.05%)
lincluding 2,344 with birth defects (0.11%), 658 family history of neonatal death (0.03%), 603 family history of Mediterranean anemia (0.03%), 274 family history of
G6PD deficiency (0.01%), 248 mental retardation (0.01%), 138 family history of Albinism (0.01%), 78 family history of Down’s syndrome (0.00%), 4 family history of
hearing impairment (0.00%), 1family history of hemophilia (0.00%) and 1family history of visual impairment (0.00%)
Zhou et al. BMC Health Services Research  (2016) 16:689 Page 5 of 7
Zhou et al. BMC Health Services Research  (2016) 16:689 Page 6 of 7Discussion
This nation-wide free preconception care project target-
ing rural areas in China used an integrated model of
PCC including both women and men. A novel classifica-
tion system was used to classify risk factors based on
their amenability to prevention and treatment, which
stratified couples in five different risk categories. More
than 68% of couples with conception plans within the
next six months had one or more risk factors, and nearly
40% of these risk factors could be potentially modified
by intervention before or during pregnancy. Approxi-
mately 23% of risk factors among women were in cat-
egory A and B, whereas among men the figure was 45%.
Avoidable risk factors were more common among men
compared with women suggesting that men may have
riskier behavior than women, with almost 30% of men
reporting consumption of alcohol and smoking.
Our study revealed that preconception risk evaluation
in couples with plans to conceive within six months
could be meaningful as nearly two-thirds of the re-
cruited couples had preconception risk factors, and 23%
maternal risk factors were in category A and B, and
thereby potentially avoidable or modifiable preconcep-
tionally by health education, medical intervention and
life style changes. More importantly, a similar situation
was observed regarding paternal risk factors. Almost
45% of the male partners consumed alcohol or smoked,
which may lead to passive smoking by women, a fact
often ignored in preconception care. Some European
countries have preconception care recommendations for
women with chronic diseases, such as diabetes and epi-
lepsy, but guidelines are heterogeneous and recommen-
dations for healthy women and men are fragmented and
inconsistent [22]. Our results further enforce the need
for an integrated approach to PCC that includes both
women and men.
A more innovative and integrated approach to PCC
for both women and men is needed for achieving opti-
mal reproductive health status before pregnancy and
better pregnancy outcomes [23, 24]. Preconception
health promotion may be useful in eliminating some of
the Category A and B risk factors before pregnancy.
However, some risk factors, such as smoking, alcohol
and substance abuse, would require longer term strat-
egies to achieve sustained amelioration. A more compre-
hensive health promotion strategy during pregnancy
would be required for managing other risk categories to
achieve better pregnancy outcomes.
The preconception risk classification system used in
this big population-based study was practical for stratify-
ing preconception health status of the couples, and help-
ful in organizing targeted educational and health care
interventions, and identifying need for referral. The risk
classification was based on existing risk factors duringthe preconception period and categorized by whether it
could be prenatally avoided or modified during the pre-
conception period or prenatally. As preconception risks
may vary from prenatal risks, Considering different
methods and timing of intervention is important. Nearly
half of the risk factors identified were avoidable or pre-
ventable by medical intervention during the preconcep-
tion period in this study, allowing for a window of
opportunity for personalized lifestyle modification and
health care to achieve better pregnancy outcome. Des-
pite the evidence supporting the value and importance
of PCC [25], it is reported that there is lack of sufficient
research attention to clinical PCC service delivery, and a
more detailed consideration of the practicalities of
implementing PCC within contemporary women’s health
care is required [26]. This integrated universal free PCC
service provided in rural China could be a promising
model if its positive impact on pregnancy outcomes
could be demonstrated in future.
Our study does have some limitations. Follow-up of
risk modifications was not included in this study, so the
impact of preconception risk classification on the health
status of the couple could not be assessed. Prevalence of
adverse pregnancy history and chronic disease history in
couples planning pregnancy might have been underesti-
mated as this was based on self-reporting and recall bias
cannot be excluded.
Conclusions
This project provided new insights into preconception
health of Chinese couples of reproductive age. More
than half of the male partners planning to father a child
were exposed to risk factors during the preconception
period, suggesting that an integrated approach to PCC
including both women and men is justified. Stratification
based on the new risk classification model demonstrated
that a majority of the risk factors are avoidable or pre-
ventable by medical intervention. Therefore, universal
free PCC can be expected to improve pregnancy out-
comes in rural China.
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